VOYA Investment Management
ANIP icon

VOYA Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

VOYA Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Buy
7,534
+751
+11% +$60.2K ﹤0.01% 1714
2026
Q1 		$522K Sell
6,783
-70
-1% -$5.46K ﹤0.01% 1700
2025
Q4 		$541K Buy
6,853
+46
+0.7% +$3.98K ﹤0.01% 1709
2025
Q3 		$624K Sell
6,807
-8,089
-54% -$660K ﹤0.01% 1662
2025
Q2 		$972K Buy
14,896
+5,962
+67% +$388K ﹤0.01% 1594
2025
Q1 		$598K Buy
8,934
+957
+12% +$57.2K ﹤0.01% 1787
2024
Q4 		$441K Sell
7,977
-459
-5% -$26.4K ﹤0.01% 1995
2024
Q3 		$503K Sell
8,436
-151
-2% -$9.21K ﹤0.01% 1994
2024
Q2 		$547K Buy
8,587
+3,743
+77% +$243K ﹤0.01% 1952
2024
Q1 		$335K Sell
4,844
-927
-16% -$56K ﹤0.01% 2196
2023
Q4 		$318K Buy
5,771
+84
+1% +$4.63K ﹤0.01% 2314
2023
Q3 		$330K Buy
5,687
+485
+9% +$28K ﹤0.01% 2260
2023
Q2 		$280K Buy
+5,202
New +$231K ﹤0.01% 2402
2023
Q1 		– Sell
-5,019
Closed -$202K – 2887
2022
Q4 		$202K Buy
+5,019
New +$189K ﹤0.01% 2567
2020
Q1 		– Sell
-4,534
Closed -$280K – 2620
2019
Q4 		$280K Sell
4,534
-4,607
-50% -$305K ﹤0.01% 2213
2019
Q3 		$666K Buy
9,141
+5,646
+162% +$422K ﹤0.01% 1562
2019
Q2 		$287K Buy
3,495
+215
+7% +$15.3K ﹤0.01% 2104
2019
Q1 		$231K Buy
+3,280
New +$193K ﹤0.01% 2196
2018
Q3 		– Sell
-3,502
Closed -$234K – 2584
2018
Q2 		$234K Sell
3,502
-429
-11% -$26.8K ﹤0.01% 2287
2018
Q1 		$229K Hold
3,931
– – ﹤0.01% 2248
2017
Q4 		$253K Sell
3,931
-261
-6% -$16.2K ﹤0.01% 2225
2017
Q3 		$220K Buy
+4,192
New +$200K ﹤0.01% 2337
2017
Q1 		– Sell
-3,556
Closed -$216K – 2506
2016
Q4 		$216K Hold
3,556
– – ﹤0.01% 2251
2016
Q3 		$236K Buy
+3,556
New +$222K ﹤0.01% 2189
2015
Q3 		– Sell
-3,556
Closed -$221K – 2569
2015
Q2 		$221K Buy
+3,556
New +$212K ﹤0.01% 2432

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VOYA Investment Management's ANIP Position: Q2 2026 in Review

VOYA Investment Management increased its ANI Pharmaceuticals (ANIP) stake by 11% in Q2 2026, buying an estimated $60.2K and bringing the position to 7,534 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

VOYA Investment Management first reported a position in ANIP in Q2 2015 and has held it in 25 quarters since. The position peaked at $972K in Q2 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • VOYA Investment Management held 7,534 shares of ANI Pharmaceuticals worth $624K as of Q2 2026.
  • VOYA Investment Management bought 751 ANI Pharmaceuticals shares in Q2 2026, an estimated $60.2K.
  • ANI Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1714 holding.
  • VOYA Investment Management first reported a position in ANI Pharmaceuticals in Q2 2015 and has held it in 25 quarters since.
  • VOYA Investment Management's ANI Pharmaceuticals position peaked at $972K in Q2 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.